AIM ImmunoTech, Inc.
(NYSE Amex Equities : AIM)

( )
AIM After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. -0.10%159.870.0%$1295.48m
AMGNAmgen, Inc. 2.21%255.131.3%$694.68m
SNSSSunesis Pharmaceuticals, Inc. 1.90%8.030.7%$561.33m
NVAXNovavax, Inc. 0.37%202.0980.0%$556.50m
ILMNIllumina, Inc. 0.98%401.963.5%$517.94m
GILDGilead Sciences, Inc. 0.72%65.771.0%$463.29m
REGNRegeneron Pharmaceuticals, Inc. 2.80%494.642.7%$449.68m
VRTXVertex Pharmaceuticals, Inc. 1.83%221.101.9%$383.88m
ALXNAlexion Pharmaceuticals, Inc. 1.45%157.542.0%$298.86m
BNTXBioNTech SE 6.12%140.720.0%$266.37m
BIIBBiogen, Inc. 1.75%270.441.7%$264.45m
EXASEXACT Sciences Corp. 2.66%130.5218.4%$192.20m
NBIXNeurocrine Biosciences, Inc. -0.05%95.004.9%$177.73m
CRSPCRISPR Therapeutics AG 0.60%123.850.6%$174.50m
SGENSeagen Inc. 3.77%149.645.8%$153.69m

Company Profile

AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. The Ampligen is used in the treatment of chronic fatigue syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Ocala, FL.